The CGESC, located on the second floor of the Genetic Medicine Building, will offer both arrayed screens and pooled whole-genome screens. Both services include screen design, experimental work, and detailed analysis. While the center is primarily for use by UNC PIs, services will be available to external users, including other universities and biotech companies.
The new facility was made possible by a cross-campus collaboration driven by Eshelman Innovation (formerly Eshelman Institute for Innovation), and supported by the Lineberger Comprehensive Cancer Center, the Eshelman School of Pharmacy, the School of Medicine, and the Office of the Vice Chancellor for Research. In addition, NC Biotech provided a generous equipment grant to help purchase key machinery for the facility.
“I am thrilled to bring a modern genetic and epigenetic screening facility to UNC’s laboratories. The CGESC will enable many future discoveries and fill UNC’s drug discovery teams with new project pipelines,” said CRISPR Facility Director Nate Hathaway, Associate Professor in the UNC Eshelman School of Pharmacy. “With CRISPR, we have the ability to continue to help patients struggling with the world’s most challenging health issues.”
The CGESC is currently accepting proposals for screens through their website. Interested researchers may also reach out by email to discuss their project—CRISPR@unc.edu.
